Skip to main content

Table 1 Clinical characteristics of controls and patients

From: Lung CD4+ Vα2.3+ T-cells in sarcoidosis cohorts with Löfgren’s syndrome

 Healthy controlsNon- sarcoidosisLSNon-LS
Subjects (n)6939274475
Gender M/F (n)30/3921/18164/110320/155
Age, yearsa24 (18–56)56 (23–78)39 (21–72)46 (24–78)
Never-smokers (n)6924144251
Lymphocytesb6.0 (0.4–28.4)22.5 (1.5–86.2)23.9 (1.0–76.6)26.7 (1.2–85.7)
CD4/CD8-ratioa1.7 (0.3–6.4)1.4 (0.2–3.2)9.3 (0.4–56.8)6.9 (0.4–46.0)
V-alfa 2.3b4.5 (1.6–18.9)5.3 (1.0–26.0)21.2 (0.3–50.0)6.4 (0.2–44.3)
  1. aValues are median (min-max). b Values are percentages of bronchoalveolar lavage cells (min-max). LS Löfgren’s syndrome. In 26 sarcoidosis patients there were no data about CD4/CD8-ratio. There were no data regarding smoking history in 2 LS patients and 3 non-LS patients